Aino Health AB (publ) (AINO.ST)
SEK 0.14
(0.0%)
SEK 0.14
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.27 Million SEK | 15.21% |
| 2022 | -1.49 Million SEK | -346.55% |
| 2021 | 608 Thousand SEK | 108.09% |
| 2020 | -7.51 Million SEK | -180.9% |
| 2019 | -2.67 Million SEK | 74.42% |
| 2018 | -10.45 Million SEK | -24.58% |
| 2017 | -8.39 Million SEK | 77.71% |
| 2016 | -37.66 Million SEK | -2412.09% |
| 2015 | 1.62 Million SEK | -13.58% |
| 2014 | 1.88 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -547 Thousand SEK | 56.96% |
| 2024 Q2 | -39 Thousand SEK | 92.87% |
| 2023 Q3 | -2.72 Million SEK | -842.21% |
| 2023 Q2 | -289 Thousand SEK | 27.75% |
| 2023 Q1 | -400 Thousand SEK | 73.32% |
| 2023 FY | -1.27 Million SEK | 15.21% |
| 2023 Q4 | -1.27 Million SEK | 53.32% |
| 2022 Q3 | 292 Thousand SEK | -50.42% |
| 2022 Q1 | 65 Thousand SEK | -89.31% |
| 2022 FY | -1.49 Million SEK | -346.55% |
| 2022 Q4 | -1.49 Million SEK | -613.36% |
| 2022 Q2 | 589 Thousand SEK | 806.15% |
| 2021 Q3 | 170 Thousand SEK | 108.32% |
| 2021 FY | 608 Thousand SEK | 108.09% |
| 2021 Q4 | 608 Thousand SEK | 257.65% |
| 2021 Q2 | -2.04 Million SEK | 48.07% |
| 2021 Q1 | -3.93 Million SEK | 47.62% |
| 2020 Q4 | -7.51 Million SEK | -2935.47% |
| 2020 FY | -7.51 Million SEK | -180.9% |
| 2020 Q1 | -134 Thousand SEK | 94.99% |
| 2020 Q2 | 1.97 Million SEK | 1571.64% |
| 2020 Q3 | 265 Thousand SEK | -86.56% |
| 2019 FY | -2.67 Million SEK | 74.42% |
| 2019 Q1 | -5.86 Million SEK | 43.93% |
| 2019 Q4 | -2.67 Million SEK | -12059.09% |
| 2019 Q3 | -22 Thousand SEK | 99.37% |
| 2019 Q2 | -3.51 Million SEK | 40.08% |
| 2018 Q1 | 30 Thousand SEK | 100.36% |
| 2018 FY | -10.45 Million SEK | -24.58% |
| 2018 Q4 | -10.45 Million SEK | -1198.42% |
| 2018 Q3 | 952 Thousand SEK | 181.86% |
| 2018 Q2 | -1.16 Million SEK | -3976.67% |
| 2017 Q3 | -14.96 Million SEK | 39.36% |
| 2017 FY | -8.39 Million SEK | 77.71% |
| 2017 Q1 | -32.21 Million SEK | 14.46% |
| 2017 Q4 | -8.39 Million SEK | 43.91% |
| 2017 Q2 | -24.67 Million SEK | 23.41% |
| 2016 Q3 | 156 Thousand SEK | 0.0% |
| 2016 Q4 | -37.66 Million SEK | -24243.59% |
| 2016 FY | -37.66 Million SEK | -2412.09% |
| 2015 FY | 1.62 Million SEK | -13.58% |
| 2014 FY | 1.88 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bonzun AB (publ) | 351 Thousand SEK | 462.108% |
| Kontigo Care AB (publ) | -3.9 Million SEK | 67.427% |
| Medhelp Care Aktiebolag (publ) | -8.26 Million SEK | 84.622% |
| RaySearch Laboratories AB (publ) | 185.67 Million SEK | 100.685% |
| Surgical Science Sweden AB (publ) | -581.1 Million SEK | 99.781% |